InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,464.40
(
0.26%
)
Dow Jones
38,675.68
(
0.00%
)
Brent Oil
83.47
(
0.41%
)
Bitcoin
64,292.40
(
0.46%
)
Post# of 106830
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Gsdubb

Send PM Follow Ignore
Followers 20
Posts 1673
Boards Moderated 0
Alias Born 08/29/2013

Gsdubb

Re: InvestorStemCell post# 11456

Saturday, 10/25/2014 12:05:46 PM

Saturday, October 25, 2014 12:05:46 PM

Post# of 106830
The $3million will kick start the trials then retail investors will come in more IMO. The past PR's regarding money from Northstar, Vitalmex, etc. never went through I don't believe per the SEC documents.

NVLX is a good example like you say, but Bioheart has approved phase 3 trials for Heart failure! This is really big IMO.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!